(Total Views: 334)
Posted On: 09/23/2020 1:44:01 AM
Post# of 653
$RLFTF Relief partner NeuroRx submits request for Emergency Use Authorization for RLF-100™ (aviptadil) in the treatment of patients with Critical COVID-19 and Respiratory Failure who have exhausted approved therapy
Emergency Use Authorization request targets the same population as is currently permitted under FDA Expanded Access Protocol
Geneva, Switzerland, and Radnor, PA, September 23, 2020
https://relieftherapeutics.com/relief-partner...hausted-a/
Emergency Use Authorization request targets the same population as is currently permitted under FDA Expanded Access Protocol
Geneva, Switzerland, and Radnor, PA, September 23, 2020
https://relieftherapeutics.com/relief-partner...hausted-a/
(0)
(0)
$MJ
